Hikma Pharmaceuticals PLC announced that Dr. Hafrun Fridriksdottir has been appointed President of its Generics business, effective 15 April 2024. Hafrun will report to Riad Mishlawi, Hikma's Chief Executive Officer, and joins the senior management team as a member of Hikma's Executive Committee. She will be based in the company's Berkeley Heights, New Jersey offices.

Hafrun succeeds Brian Hoffmann, who will leave Hikma effective May 1st. Hafrun brings more than 25 years of pharmaceutical industry experience to her new role. During her career, Hafrun has held senior executive and research and development positions at leading global pharmaceutical companies including Alvotech, Teva Pharmaceuticals, Allergan and Actavis, and most recently has served in advisory and board roles for several biotech and mid-sized pharma companies.